Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

Small-Cap Surge: Vanguard’s Russell 2000 ETF Rides a Wave of Momentum

Andreas Sommer by Andreas Sommer
January 21, 2026
in ETF, Market Commentary, Value & Growth
0
Vanguard Russell 2000 Index Fund ETF Shares Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

A significant rotation into smaller companies is defining the current market landscape. With interest rates stabilizing following the Federal Reserve’s cuts in late 2025 and fresh fiscal stimulus providing relief, small and mid-cap stocks are enjoying a pronounced tailwind. This shift has propelled the Russell 2000 index to a year-to-date gain of nearly 8%, achieving new record highs. The Vanguard Russell 2000 Index Fund ETF Shares (VTWO) is a primary vehicle capturing this move.

Performance and Trading Activity
As of January 16, 2026, VTWO has delivered a year-to-date return of 7.91% based on its market price, with an almost identical net asset value (NAV) return of 7.92%. Short-term performance metrics show a gain of 2.11% for the week of January 9-16 and a 6.43% advance over the one-month period from December 18 to January 16. For the three months ended December 31, 2025, the ETF returned 2.1%. The fund’s full-year return for 2025 was 12.90%.

Trading volume has notably increased, underscoring growing investor interest. On January 20, 2026, share volume reached 5.37 million, substantially above the 50-day average of 2.74 million. The ETF has traded efficiently, with a tight spread between its market price and NAV. Recent examples include a minor discount of -0.02% on January 12, a maximum premium of 0.06% on January 13, and a maximum discount of -0.07% on January 6.

Portfolio Composition and Sector Exposure
VTWO employs a full-replication strategy to track the Russell 2000 index, holding approximately 1,993 securities as of January 16, 2026. The fund is notably diversified, with its ten largest holdings accounting for just 5.16% of total assets, thereby minimizing concentration risk.

Top Holdings (Weight):
* Credo Technology Group: 0.79%
* Bloom Energy: 0.79%
* Fabrinet: 0.56%
* IonQ: 0.46%
* Nextpower: 0.45%
* Guardant Health: 0.44%
* Kratos Defense: 0.43%
* BridgeBio Pharma: 0.38%
* Madrigal Pharmaceuticals: 0.38%
* Coeur Mining: 0.37%

The sector allocation, also current to January 16, 2026, is led by Health Care (18.89%), followed by Financials (16.77%), Technology (15.61%), Industrials (15.51%), and Consumer Cyclical (9.20%). Roughly 90% of the fund’s exposure is to U.S.-based companies.

Should investors sell immediately? Or is it worth buying Vanguard Russell 2000 Index Fund ETF Shares?

Competitive Landscape and Key Metrics
VTWO competes directly with other Russell 2000 ETFs, most notably the iShares Russell 2000 ETF (IWM) and the Invesco Russell 2000 ETF (RSSL). A primary advantage for VTWO is its low expense ratio of 0.07% (as of December 2025). For comparison, IWM has an expense ratio of 0.19% and assets under management (AUM) of $76.31 billion, while RSSL charges 0.08% and has AUM of $1.39 billion. VTWO and IWM both use a full-replication methodology, whereas RSSL tracks a capped version of the Russell 2000 index.

Fundamental Data:
* Russell 2000 Index YTD Return: Nearly +8% (as of today’s date)
* VTWO YTD Return (Market Price/NAV): 7.91% / 7.92% (as of Jan. 16, 2026)
* VTWO Assets Under Management: $14.35 billion (as of Jan. 19, 2026)

Forward-Looking Factors and Outlook
Several developments are poised to influence the small-cap segment in the coming months. A major operational change is the shift to a semi-annual reconstitution schedule for the Russell US Indices in 2026, with rebalancing set for the fourth Friday in June and the second Friday in December, effective starting December 14, 2026.

From a macro and technical perspective, the combination of an accommodative Fed policy and a bullish “Golden Cross” pattern for the Russell 2000 index—where its 50-day moving average has crossed above its 200-day average—is supporting positive momentum. The 50-day moving average is currently acting as a key technical support level.

The performance trajectory for VTWO and small caps broadly will be largely dictated by the upcoming index rebalances and the evolving monetary policy landscape. Sustained interest rate stability coupled with continued economic growth would likely provide additional support for the fund in the months ahead.

Ad

Vanguard Russell 2000 Index Fund ETF Shares Stock: Buy or Sell?! New Vanguard Russell 2000 Index Fund ETF Shares Analysis from February 7 delivers the answer:

The latest Vanguard Russell 2000 Index Fund ETF Shares figures speak for themselves: Urgent action needed for Vanguard Russell 2000 Index Fund ETF Shares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Vanguard Russell 2000 Index Fund ETF Shares: Buy or sell? Read more here...

Tags: Vanguard Russell 2000 Index Fund ETF Shares
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Schnitzer Steel Industries Stock
Analysis

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

February 6, 2026
Luxor Industrialration Stock
Commodities

Industrial Timber Sector Eyes a Path to Stability

February 6, 2026
Next Post
Nvidia Stock

Nvidia's AI Ambition Receives Fresh Validation from Industry Leaders

Solana Stock

Solana Defies Market Downturn with Unprecedented Staking Activity

Bitcoin Stock

Bitcoin Navigates Volatile Terrain Amid Institutional Shifts

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com